Page last updated: 2024-10-22

amifostine anhydrous and Cancer of Testis

amifostine anhydrous has been researched along with Cancer of Testis in 2 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dunn, TA1
Schmoll, HJ1
Grünwald, V1
Bokemeyer, C1
Casper, J1
Cronin, S1
Uberti, JP1
Ayash, LJ1
Raith, C1
Ratanatharathorn, V1

Other Studies

2 other studies available for amifostine anhydrous and Cancer of Testis

ArticleYear
Amifostine does not alter the antitumor activity of cisplatin in a pre-clinical model of testicular cancer.
    Anti-cancer drugs, 1996, Volume: 7, Issue:7

    Topics: Adult; Amifostine; Animals; Antineoplastic Agents; Cisplatin; Germinoma; Humans; Lethal Dose 50; Mal

1996
Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem cell transplantation.
    Bone marrow transplantation, 2000, Volume: 26, Issue:11

    Topics: Adult; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin

2000